Atrial fibrillation hospitalization, mortality, and therapy
نویسندگان
چکیده
منابع مشابه
Atrial fibrillation and mortality.
of cardiovascular death, after adjustment for the decreasing cardiovascular mortality rate in the general population. Does this mean we are getting better at managing atrial fibrillation? Are new drugs and novel electrophysiological techniques making an impact? The report from Frost et al. is dependant upon the Danish National Hospital Discharge Register statistics, where only a 50% random samp...
متن کاملAtrial fibrillation and mortality: the impact of antithrombotic therapy.
All of the current guidelines on antithrombotic therapy for atrial fibrillation (AF) emphasize the prevention of stroke and thromboembolism as the primary goal of such treatment, and existing recommendations for antithrombotic therapy are based on an individual patient’s risk of stroke. These guidelines have been formulated from the numerous clinical trials of antithrombotic therapy in patients...
متن کاملMortality of Atrial Fibrillation
The title of John Iacovino’s mortality risk analysis1 of the Framingham Heart Study of Benjamin et al2 is "Mortality of Atrial Fibrillation in a Population Selected to be Free of Major Cardiovascular Impairments," and Iacovino’s analysis is presented as a demonstration of "the magnitude of additional mortality produced by the development of atrial fibrillation not associated with major cardiova...
متن کاملAtrial fibrillation in chronic dialysis patients in the United states: risk factors for hospitalization and mortality
BACKGROUND The incidence and risk factors for hospitalized atrial fibrillation have not been previously assessed in a national population of dialysis patients. METHODS We analyzed the United States Renal Data System (USRDS) Dialysis Morbidity and Mortality Study (DMMS) Wave II in a historical cohort study of hospitalized atrial fibrillation. Data from 3374 patients who started dialysis in 199...
متن کاملAtrial Fibrillation Antiarrhythmic Drug Therapy for Atrial Fibrillation
Antiarrhythmic medications have been available for nearly 100 years and remain a mainstay in the management of atrial fibrillation (AF). Goals of therapy with the use of these drugs include a reduction in the frequency and duration of episodes of arrhythmia as well an emerging goal of reducing mortality and hospitalizations associated with AF. The use of these drugs has been limited by both pro...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Heart Journal
سال: 2018
ISSN: 0195-668X,1522-9645
DOI: 10.1093/eurheartj/ehy622